THINK Surgical, Inc. announced its entry into a development and distribution agreement with Curexo, Inc. THINK and Curexo have a strong working relationship based on historical development collaboration and Curexo distributes THINK's TSolution One™ platform in Korea and Vietnam. Under the development and distribution agreement, THINK and Curexo will work together to include certain existing THINK technology and certain newly developed technology in Curexo's CUVIS-Joint orthopedic surgical robot platform. THINK will have exclusive rights to distribute the CUVIS-Joint robotic platform, including the additional technology, in the United States and other countries, including the United Kingdom and certain countries in the European Union.

The CUVIS-Joint robotic platform is currently being used by surgeons in Korea and India with great success. To date over 4,000 procedures have been performed. Curexo will continue to commercialize the CUVIS-Joint robotic platform, including new technology developed with THINK, outside of the countries in THINK's distribution territory.

Curexo will also continue to distribute THINK's TSolution One™ platform in Korea and Vietnam. The CUVIS-Joint robotic platform is not yet cleared for sale in the United States. THINK will be responsible for seeking 510(k) clearance from the Food and Drug Administration (FDA) in the United States with support from Curexo to allow such sales.

The companies will work together to seek regulatory clearance in other countries for the CUVIS-Joint robotic platform including additional technology.